A study on the impact of CYP2C19 genotype and platelet reactivity assay on patients undergoing PCI

BACKGROUND: A thorough understanding of the patient's genotype and their functional response to a medication is necessary for improving event free survival. Several outcome studies support this view particularly if the patient is to be started on clopidogrel due to the prevalence of clopidogrel...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Indian Heart J
Autori principali: Rath, P.C., Chidambaram, Sundar, Rath, Pallavi, Dikshit, Byomakesh, Naik, Sudhir, Sahoo, Prashant K., Das, Brajraj, Mahalingam, Mohanshankar, Khandrika, Lakshmipathi, Jain, Jugnu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2015
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4475902/
https://ncbi.nlm.nih.gov/pubmed/26071289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ihj.2015.03.017
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi